Abstract:Abstract Background Tau pathology is a hallmark of Alzheimer’s disease (AD) and other tauopathies. During disease progression, abnormally phosphorylated forms of tau aggregate and accumulate into neurofibrillary tangles, leading to synapse loss, neuroinflammation, and neurodegeneration. Thus, targeting of tau pathology is expected to be a promising strategy for AD treatment. Methods The effect of rutin on tau aggregation was detected by thioflavin T fluorescence and transmission electron microscope imaging. The effect of rutin on tau oligomer-induced cytotoxicity was assessed by MTT assay. The effect of rutin on tau oligomer-mediated the production of IL-1β and TNF-α in vitro was measured by ELISA. The uptake of extracellular tau by microglia was determined by immunocytochemistry. Six-month-old male Tau-P301S mice were treated with rutin or vehicle by oral administration daily for 30 days. The cognitive performance was determined using the Morris water maze test, Y-maze test, and novel object recognition test. The levels of pathological tau, gliosis, NF-kB activation, proinflammatory cytokines such as IL-1β and TNF-α, and synaptic proteins including synaptophysin and PSD95 in the brains of the mice were evaluated by immunolabeling, immunoblotting, or ELISA. Results We showed that rutin, a natural flavonoid glycoside, inhibited tau aggregation and tau oligomer-induced cytotoxicity, lowered the production of proinflammatory cytokines, protected neuronal morphology from toxic tau oligomers, and promoted microglial uptake of extracellular tau oligomers in vitro. When applied to Tau-P301S mouse model of tauopathy, rutin reduced pathological tau levels, regulated tau hyperphosphorylation by increasing PP2A level, suppressed gliosis and neuroinflammation by downregulating NF-kB pathway, prevented microglial synapse engulfment, and rescued synapse loss in mouse brains, resulting in a significant improvement of cognition. Conclusion In combination with the previously reported therapeutic effects of rutin on Aβ pathology, rutin is a promising drug candidate for AD treatment based its combinatorial targeting of tau and Aβ.

Rutin Inhibits Amylin-Induced Neurocytotoxicity and Oxidative Stress.

Rutin Inhibits Β-Amyloid Aggregation and Cytotoxicity, Attenuates Oxidative Stress, and Decreases the Production of Nitric Oxide and Proinflammatory Cytokines.

Rutin prevents tau pathology and neuroinflammation in a mouse model of Alzheimer’s disease

Rutin Improves Spatial Memory in Alzheimer's Disease Transgenic Mice by Reducing Aβ Oligomer Level and Attenuating Oxidative Stress and Neuroinflammation

A Newly Synthesized Rhamnoside Derivative Alleviates Alzheimer's Amyloid-β-Induced Oxidative Stress, Mitochondrial Dysfunction, and Cell Senescence Through Upregulating SIRT3.

Sodium rutin ameliorates Alzheimer's disease-like pathology by enhancing microglial amyloid-β clearance

Retracted: Rutin Protects Against Cognitive Deficits and Brain Damage in Rats with Chronic Cerebral Hypoperfusion

Rutin Ameliorates ALS Pathology by Reducing SOD1 Aggregation and Neuroinflammation in an SOD1-G93A Mouse Model

Inhibition of Vascular Smooth Muscle Cells Premature Senescence with Rutin Attenuates and Stabilizes Diabetic Atherosclerosis.

Rutin alleviates diabetic cardiomyopathy and improves cardiac function in diabetic ApoEknockout mice

Rutin impedes human low-density lipoprotein from non-enzymatic glycation: A mechanistic insight against diabetes-related disorders

Protective Effects of Myricetin and Morin on Neurological Damage in Aβ1-42/Al3+ -Induced Alzheimer's Disease Model of Rats.

Protective Effect of Rutin on Spinal Motor Neuron in Rats Exposed to Acrylamide and the Underlying Mechanism

Rutin protects Huntington's disease through the insulin/IGF1 (IIS) signaling pathway and autophagy activity: Study in Caenorhabditis elegans model

Protective Effects of Myricetin and Morin on Neurological Damage in A Β 1-42 /al 3+-Induced Alzheimer ' S Disease Model of Rats

Rutin Inhibits Ox-LDL-Mediated Macrophage Inflammation and Foam Cell Formation by Inducing Autophagy and Modulating PI3K/ATK Signaling

Protective Effects of Myricetin and Morin on Neurological Damage in Aβ 1-42 /Al 3+ -induced Alzheimer's Disease Model of Rats

Rutin attenuates D-galactose-induced oxidative stress in rats' brain and liver: molecular docking and experimental approaches

Rutin Alleviates Diabetic Cardiomyopathy In A Rat Model Of Type 2 Diabetes

The inhibition of rutin on Src kinase blocks high glucose-induced EGFR/ERK transactivation in diabetic nephropathy by integrative approach of network pharmacology and experimental verification

Neuroprotective Effect of Resveratrol via Activation of Sirt1 Signaling in a Rat Model of Combined Diabetes and Alzheimer's Disease.